[{"from": "human", "value": "Could you give me a brief overview of this molecule? [C][Branch2][#C][=Branch1][C][S][C][C@@H1][C@@H1][C@@H1][Branch2][=C][N][C@H1][Branch2][=C][#Branch1][C@H1][Branch1][Ring2][O][Ring1][=Branch1][O][C@@H1][C@H1][Branch2][=N][C][O][C@@H1][Branch1][=Branch2][C@@H1][Branch1][Branch1][C@H1][Ring1][=Branch1][O][O][O][C@@H1][C@H1][Branch2][O][#Branch1][O][C@@H1][Branch1][=Branch2][C@@H1][Branch1][Branch1][C@H1][Ring1][=Branch1][O][O][O][C@@H1][C@H1][Branch2][=Branch2][N][O][C@@H1][Branch1][=Branch2][C@@H1][Branch1][Branch1][C@H1][Ring1][=Branch1][O][O][O][C@@H1][C@H1][Branch2][#Branch1][P][O][C@@H1][Branch1][=Branch2][C@@H1][Branch1][Branch1][C@H1][Ring1][=Branch1][O][O][O][C@@H1][C@H1][Branch2][=Branch1][=Branch1][O][C@@H1][Branch1][=Branch2][C@@H1][Branch1][Branch1][C@H1][Ring1][=Branch1][O][O][O][C@@H1][C@H1][Branch2][Ring2][O][O][C@@H1][Branch1][=Branch2][C@@H1][Branch1][Branch1][C@H1][Ring1][=Branch1][O][O][O][C@@H1][C@H1][Branch1][P][O][C@H1][Branch1][Branch1][O][Ring2][Branch1][P][C@@H1][Branch1][Branch1][C@H1][Ring1][#Branch1][O][O][C][S][C][C][C][=Branch1][C][=O][O][C][S][C][C][C][=Branch1][C][=O][O][C][S][C][C][C][=Branch1][C][=O][O][C][S][C][C][C][=Branch1][C][=O][O][C][S][C][C][C][=Branch1][C][=O][O][C][S][C][C][C][=Branch1][C][=O][O][C][S][C][C][C][=Branch1][C][=O][O][O][O][C][=Branch1][C][=O][O]"}, {"from": "gpt", "value": "The molecule is a selective relaxant binding agent indicated for reversal of neuromuscular blockade induced by rocuronium bromide and vecuronium bromide during surgery. Rocuronium bromide and vecuronium bromide are neuromuscular blocking medications that cause temporary paralysis and are especially useful for general anesthesia, ventilation, or tracheal intubation that patients may require for surgery. Sugammadex provides a new treatment option to reverse the effects of those medications and possibly help patients recover sooner post-surgery. Sugammadex (brand name Bridion) is marketed by Merck Sharp and Dohme, and was approved by the United States FDA on December 15, 2015."}]